Orange Book product · Generic (ANDA)
OLOPATADINE HYDROCHLORIDE
OLOPATADINE HYDROCHLORIDE
At a glance
Jan 31, 2017
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jan 31, 2017
9 yr 6 mo ago
Today
Pharmaceutical detail
Active ingredient
OLOPATADINE HYDROCHLORIDE
Strength
0.665MG/SPRAY
Dosage form
SPRAY, METERED
Route
NASAL
TE code
AB
Application
ANDA 202853
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of OLOPATADINE HYDROCHLORIDE
- 2015PATADAY ONCE DAILY RELIEFBrand (NDA)
NDA 206276 · ALCON LABS INC
- 2008PATANASEBrand (NDA)
NDA 021861 · NOVARTIS
- 2004PATADAY ONCE DAILY RELIEFBrand (NDA)
NDA 021545 · ALCON LABS INC
- 1996PATADAY TWICE DAILY RELIEFBrand (NDA)
NDA 020688 · ALCON LABS INC
- 2026OLOPATADINE HYDROCHLORIDEGeneric (ANDA)
ANDA 213514 · GLAND
- 2025OLOPATADINE HYDROCHLORIDEGeneric (ANDA)
ANDA 217051 · FDC LTD
- 2025OLOPATADINE HYDROCHLORIDEGeneric (ANDA)
ANDA 219557 · GLENMARK PHARMS
- 2024OLOPATADINE HYDROCHLORIDEGeneric (ANDA)
ANDA 215006 · SOMERSET
- 2020OLOPATADINE HYDROCHLORIDEGeneric (ANDA)
ANDA 213757 · HIKMA
- 2020OLOPATADINE HYDROCHLORIDEGeneric (ANDA)
ANDA 204620 · RISING
- 2020OLOPATADINE HYDROCHLORIDEGeneric (ANDA)
ANDA 209752 · GLAND
- 2020OLOPATADINE HYDROCHLORIDEGeneric (ANDA)
ANDA 208637 · FLORIDA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
